Allergy and Immunology, Allergy · Madison, WI
NPI
1376707307
Since 2008
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
20 S Park St
Madison, WI, 53715
Phone (608) 287-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$545K
17,742 services
Medicare patients, 2024
439
Average age 73
Drug cost, 2024
$776K
3,165 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark J Biagtan was code J2357 (injection, omalizumab, 5 mg), 9,660 times for 27 patients. In total Mark J Biagtan billed 17,742 services in 44 codes, and Medicare paid $545K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 9,660 | 27 | $29.54 | $285K |
| 95165 Treatment - Miscellaneous | Office | 628 | 21 | $10.30 | $6,467 |
| 96372 Injection Administration | Office | 314 | 39 | $10.05 | $3,156 |
| 99213 Office E&M - Established | Office | 295 | 265 | $58.87 | $17K |
| 95004 Test - Miscellaneous | Office | 261 | 13 | $2.03 | $531 |
| 94010 Pulmonary Function Testing | Office | 221 | 193 | $17.23 | $3,808 |
| 95117 Treatment - Miscellaneous | Office | 197 | 36 | $6.95 | $1,369 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 148 | 138 | $12.12 | $1,794 |
| 99214 Office E&M - Established | Office | 115 | 102 | $87.38 | $10K |
| 95115 Treatment - Miscellaneous | Office | 107 | 16 | $5.81 | $622 |
| 36415 Venipuncture Blood Collection | Office | 40 | 37 | $8.65 | $346 |
| 99203 Office E&M - New | Office | 25 | 25 | $74.92 | $1,873 |
| 99215 Office E&M - Established | Office | 19 | 19 | $102.89 | $1,955 |
| 95076 Test - Miscellaneous | Office | 18 | 16 | $87.47 | $1,575 |
| 99204 Office E&M - New | Office | 15 | 15 | $100.91 | $1,514 |
By year: 2022 $525K for 16,364 services; 2023 $549K for 17,030 services; 2024 $545K for 17,742 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 40 | 37 | $8.65 | $346 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark J Biagtan prescribed most often to Medicare patients was Montelukast Sodium, with 353 prescriptions and refills. In total Mark J Biagtan wrote 3,165 Medicare prescriptions that cost $776K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 353 | 959 | 103 | $5,726 |
| Azelastine Hcl Generic | 317 | 519 | 128 | $8,139 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 284 | 427 | 82 | $126K |
| Advair Hfa Fluticasone Propion/Salmeterol | 272 | 324 | 53 | $112K |
| Fluticasone Propionate Generic | 204 | 394 | 67 | $3,764 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 182 | 206 | 93 | $5,760 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 119 | 201 | 37 | $24K |
| Asmanex Hfa Mometasone Furoate | 109 | 144 | 25 | $13K |
| Ventolin Hfa Albuterol Sulfate | 102 | 106 | 56 | $6,109 |
| Breo Ellipta Fluticasone/Vilanterol | 91 | 135 | 22 | $50K |
| Epinephrine Generic | 81 | 85 | 67 | $18K |
| Dulera Mometasone/Formoterol | 78 | 109 | 20 | $35K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 68 | 103 | 21 | $13K |
| Prednisone Generic | 67 | 69 | 41 | $234 |
| Famotidine Generic | 64 | 133 | 23 | $1,026 |
Brand drugs: 1,578 claims; generic drugs: 1,587 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mark J Biagtan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.